SkinBioTherapeutics plc (LON:SBTX – Get Free Report)’s stock price was up 8.4% during mid-day trading on Monday . The stock traded as high as GBX 20.99 ($0.27) and last traded at GBX 20.98 ($0.27). Approximately 593,090 shares traded hands during trading, a decline of 5% from the average daily volume of 625,984 shares. The stock had previously closed at GBX 19.36 ($0.25).
SkinBioTherapeutics Stock Up 8.4 %
The company has a fifty day simple moving average of GBX 18.24 and a 200-day simple moving average of GBX 15.61. The company has a quick ratio of 10.01, a current ratio of 0.93 and a debt-to-equity ratio of 27.57. The firm has a market cap of £47.93 million, a P/E ratio of -12.90 and a beta of 2.01.
About SkinBioTherapeutics
SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis.
See Also
- Five stocks we like better than SkinBioTherapeutics
- Stock Market Sectors: What Are They and How Many Are There?
- How to Protect Your Portfolio When Inflation Is Rising
- How to trade penny stocks: A step-by-step guide
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- Earnings Per Share Calculator: How to Calculate EPS
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for SkinBioTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SkinBioTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
